Semler Scientific® Announces Earnings Release Date and Live Video Webinar for Second Quarter 2025 Financial Results

Company Overview - Semler Scientific, Inc. is the second U.S. public company to adopt Bitcoin as its primary treasury reserve asset [3] - The company is a leader in medical devices and software aimed at combating chronic diseases [3] - Semler Scientific's flagship product, QuantaFlo, is FDA-cleared and provides rapid point-of-care testing for measuring arterial blood flow [3] Financial Reporting - Semler Scientific will report its financial results for the second quarter ended June 30, 2025, on August 4, 2025, after U.S. market close [1] - A live video webinar will be hosted by CEO Doug Murphy-Chutorian at 4:30 pm ET on the same day [1] Strategic Initiatives - The company plans to strategically accumulate Bitcoin using proceeds from equity and debt financings, as well as cash flows from operations [3] - Semler Scientific, along with its subsidiary CardioVanta, develops and markets products for early detection and monitoring of chronic diseases [3]